![](https://www.fda.gov/themes/custom/preview/img/FDA-Social-Graphic.png)
FDA Roundup: July 23, 2024
For Immediate Release: July 23, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Monday, the FDA approved Femlyv (norethindrone acetate and ethinyl estradiol), the first orally …